SamuelZacharyGoldhaberMD

Preventive Cardiology, Vascular Medicine

Professor of Medicine, Harvard Medical School; Associate Chief and Clinical Director, Division of Cardiovascular Medicine, BWH; Director, Thrombosis Research Group, BWH

Join to view full profile

Dr. Goldhaber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Goldhaber's full profile

Already have an account?

Office
75 Francis St
Boston, MA 02115
Phone+1 857-307-1932

Education & Training

Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1979 - 1982
Brigham and Women's HospitalResidency, Internal Medicine, 1976 - 1979
Harvard Medical SchoolClass of 1976

Certifications & Licensure

MA State Medical License 1979 - 2025
FL State Medical License 2022 - 2024
ME State Medical License 2021 - 2024
NH State Medical License 2022 - 2024
RI State Medical License 2022 - 2024
CT State Medical License 2021 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Fellow (FAHA) American Heart Association
Fellow (FESC) European Society of Vascular Medicine)
Fellow (FACC) American College of Cardiology
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

Multi-Center Human Alert Trial to Prevent DVT and PE Start of enrollment: 2006 Mar 01
Completed
Gastrointestinal Ulceration in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Start of enrollment: 2006 Apr 01
Completed
Not Applicable
Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism Start of enrollment: 2006 May 01
Completed
Not Applicable
Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism Start of enrollment: 2006 Apr 01
Completed
Not Applicable
Heparin Induced Thrombocytopenia: Pharmacoeconomics Start of enrollment: 2006 Jul 01
Completed
Epidemiology of Venous Thromboembolism Start of enrollment: 2006 Apr 01
Completed
Heparin-Induced Thrombocytopenia Registry Start of enrollment: 2005 Oct 01
Completed
Registry of Hospitalized Patients Treated With Fondaparinux Start of enrollment: 2007 Jul 01
Completed
3 Screen Electronic Alert Start of enrollment: 2007 Jul 01
Completed
Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge Start of enrollment: 2008 Feb 01
Completed
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis Start of enrollment: 2009 Nov 01
Completed
Phase 3
Discharge ALERT: Quality Improvement Initiative Start of enrollment: 2009 Apr 01
Completed
Not Applicable
Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy Start of enrollment: 2012 Jun 07
Completed
Phase 3
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis Start of enrollment: 2012 Aug 01
Completed
Phase 2
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Optimizing Low-Density Lipoprotein Management Start of enrollment: 2021 Oct 08
Active, not recruiting
Not Applicable
Roles: Sub-Investigator
Join now to see all

Publications & Presentations

PubMed

1848 citations
Dabigatran versus warfarin in the treatment of acute venous thromboembolism
Sam Schulman, Clive Kearon, Ajay K. Kakkar, Patrick Mismetti, Sebastian Schellong
The New England Journal of Medicine. 2009-12-16
37 citations
Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials.
Candrika D Khairani, Antoine Bejjani, Gregory Piazza, David Jimenez, Manuel Monreal
Journal of the American College of Cardiology. 2023-01-03
112 citations
International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, an...
Benjamin A. Steinberg, Haiyan Gao, Peter Shrader, Karen S. Pieper, Laine Thomas
American Heart Journal. 2017-12-01

Journal Articles

Asymptomatic Deep Vein Thrombosis Is Associated with an Increased Risk of Death: Insights from the APEX Trial
Iqra Qamar, Gerald Chi, Adrian F Hernandez, C Michael Gibson, Serge Korjian, Samuel Z Goldhaber, Thrombosis and Haemostasis

Lectures

ECMO and Surgical Embolectomy
Harvard Medical School, Boston, Massachusetts - 10/18/2012
Thromboembolism Prophylaxis for Patients Discharged from the Hospital Easier Said Than Done
Harvard Medical School ,Department Of Continuing Education, Boston, Massachusetts - 3/4/2013
Panelist: Case 1
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Prospective Study of Apixaban for Primary Prevention of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Protecting Our Vulnerable, Medically Ill Patients From Venous Thromboembolism
60th American Society of Hematology Annual Meeting - 11/30/2018
Join now to see all

Authored Content

ECMO and Surgical EmbolectomyAugust 2020
Thromboembolism Prophylaxis for Patients Discharged from the Hospital Easier Said Than DoneJune 2020

Press Mentions

Blood Clot Prevention: Three Stretches That Could Help You Prevent the Deadly ConditionApril 7th, 2021
Covid Vaccine Side Effects: Thrombosis Reported in Patients - What Is It?March 12th, 2021
Surgical Management of Acute PE Provides Good OutcomesAugust 20th, 2020
Join now to see all